Vishay Intertechnology, Inc. (VSH) - Q3 2024 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the fiscal quarter ended September 28, 2024. Vishay Intertechnology, Inc. is a global manufacturer of discrete semiconductors and passive electronic components operating in six segments: MOSFETs, Diodes, Optoelectronic Components, Resistors, Inductors, and Capacitors. The company continues to navigate a distributor inventory correction and has adjusted its capital expenditure timeline for its new 12-inch wafer fab in Itzehoe, Germany, due to slower-than-expected industry recovery.
Key Financial Metrics
| Metric | Q3 2024 | Q3 2023 | 9 Months 2024 | 9 Months 2023 |
|---|---|---|---|---|
| Net Revenues | $735.4 million | $853.7 million | $2,222.9 million | $2,616.8 million |
| Gross Profit | $150.9 million | $237.6 million | $484.2 million | $773.8 million |
| Gross Margin | 20.5% | 27.8% | 21.8% | 29.6% |
| Operating Income (Loss) | $(18.3) million | $115.1 million | $62.3 million | $408.3 million |
| Net Earnings (Loss) Attributable to Vishay | $(19.3) million | $65.5 million | $35.2 million | $272.3 million |
| Diluted EPS | $(0.14) | $0.47 | $0.25 | $1.94 |
| Cash and Cash Equivalents | $643.8 million | $972.7 million (Dec 31, 2023) | - | - |
| Long-Term Debt | $820.8 million | $818.2 million (Dec 31, 2023) | - | - |
| Free Cash Flow (9 Months) | $(67.7) million | $176.4 million | - | - |
Material Changes vs. Prior Period
- Revenue Decline: Q3 revenues decreased 13.9% year-over-year, driven primarily by lower sales volume (-11.0%) and decreased average selling prices (-4.7%). The distributor inventory correction continues to impact orders and backlog.
- Restructuring Charges: The company recorded $40.6 million in restructuring and severance costs in Q3 2024, compared to none in the prior year. This included costs for closing three manufacturing facilities (Shanghai, Fichtelberg, Milwaukee) and streamlining SG&A functions.
- Operating Loss: Due to the revenue decline and restructuring charges, the company reported an operating loss of $18.3 million in Q3, a significant shift from the $115.1 million operating income in Q3 2023.
- Acquisitions: The company completed the acquisition of Nexperia's Newport wafer fab ($177.5 million) in Q1 and Ametherm, Inc. ($31.5 million) in Q2. These acquisitions contributed to revenue but also added depreciation and integration costs.
- Segment Performance: The MOSFETs segment reported an operating loss of $4.3 million in Q3, down from $52.8 million in Q3 2023, largely due to the impact of the Newport acquisition and lower volumes. The Resistors and Inductors segments remained profitable.
Guidance, Outlook, and Risks
- Capital Expenditures: Management adjusted its 2024 capital expenditure guidance to a range of $360 million to $390 million, down from the initial plan of approximately $435 million, due to the slower industry recovery. The company remains committed to a $2.6 billion total spend for 2023-2028.
- Goodwill Impairment Test: An interim goodwill impairment test was performed in Q3 due to share price declines and increased asset book value. No impairment was recognized, but the MOSFETs reporting unit's fair value exceeded its carrying value by less than 10%, indicating a narrow margin of safety.
- Stockholder Return Policy: The company continues its policy to return at least 70% of free cash flow (net of debt principal payments) via dividends and share repurchases. In Q3, the company repurchased $12.6 million of stock and paid $13.6 million in dividends.
- Liquidity and Debt: The company has a $750 million revolving credit facility with no outstanding balance as of period end. Subsequent to the quarter, the company repurchased $40.7 million of 2025 convertible notes using a draw on this facility.
- Risks: Key risks include the continuation of the distributor inventory correction, execution risks related to strategic capacity expansions (Itzehoe and Newport), and potential future goodwill impairment if the MOSFETs segment underperforms.
Investor Verification Checklist
- Restructuring Impact: Verify the timeline and expected annualized savings ($12 million) from the announced restructuring program and facility closures.
- MOSFETs Segment Viability: Monitor the MOSFETs segment closely, as it is the only segment reporting an operating loss and has a narrow goodwill impairment buffer.
- Capital Expenditure Execution: Track the revised 2024 CapEx spend against the $360-$390 million guidance and the long-term $2.6 billion commitment.
- Free Cash Flow Recovery: Assess the timeline for free cash flow recovery given the negative $67.7 million YTD result, driven by CapEx and tax payments.
- Debt Management: Confirm the impact of the subsequent repurchase of 2025 convertible notes on the company's leverage ratios and liquidity position.